Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2008 Nov 17;587(Pt 1):155–163. doi: 10.1113/jphysiol.2008.164707

Calcium- and myosin-dependent changes in troponin structure during activation of heart muscle

Yin-Biao Sun 1, Fang Lou 2, Malcolm Irving 1
PMCID: PMC2670030  PMID: 19015190

Abstract

Each heartbeat is triggered by a pulse of intracellular calcium ions which bind to troponin on the actin-containing thin filaments of heart muscle cells, initiating a change in filament structure that allows myosin to bind and generate force. We investigated the molecular mechanism of calcium regulation in demembranated trabeculae from rat ventricle using polarized fluorescence from probes on troponin C (TnC). Native TnC was replaced by double-cysteine mutants of human cardiac TnC with bifunctional rhodamine attached along either the C helix, adjacent to the regulatory Ca2+-binding site, or the E helix in the IT arm of the troponin complex. Changes in the orientation of both troponin helices had the same steep Ca2+ dependence as active force production, with a Hill coefficient (nH) close to 3, consistent with a single co-operative transition controlled by Ca2+ binding. Complete inhibition of active force by 25 μm blebbistatin had very little effect on the Ca2+-dependent structural changes and in particular did not significantly reduce the value of nH. Binding of rigor myosin heads to thin filaments following MgATP depletion in the absence of Ca2+ also changed the orientation of the C and E helices, and addition of Ca2+ in rigor produced further changes characterized by increased Ca2+ affinity but with nH close to 1. These results show that, although myosin binding can switch on thin filaments in rigor conditions, it does not contribute significantly under physiological conditions. The physiological mechanism of co-operative Ca2+ regulation of cardiac contractility must therefore be intrinsic to the thin filaments.


Contraction of heart muscle is driven by an interaction between myosin, actin and MgATP that is controlled on a beat-to-beat basis by transient binding of Ca2+ ions to the troponin/tropomyosin complex in the actin-containing thin filaments (Tobacman, 1996; Gordon et al. 2000; Kobayashi & Solaro, 2005). Although the structures of most of the major protein components of the regulatory complex have been elucidated, the physiological mechanism of the control of cardiac contractility is not yet understood at the molecular level. Activation and relaxation of heart muscle cells occur over a narrow range of Ca2+ concentrations, and the steep Ca2+ dependence of the regulatory mechanism indicates a high degree of co-operativity. This might be due to coupling between adjacent actin/tropomyosin/troponin units in the thin filament (Tobacman & Sawyer, 1990; Tobacman, 1996; Galinska-Rakoczy et al. 2008) or to activation of the thin filament by myosin binding (Bremel & Weber, 1972; Rosenfeld & Taylor, 1985; Robinson et al. 2004). Both these mechanisms can operate under specific conditions in vitro, but the nature of the structural changes and co-operative interactions that occur during physiological activation of the heart cannot be reliably extrapolated from in vitro studies.

Here we have investigated the molecular mechanism of Ca2+ regulation of cardiac contractility in demembranated ventricular trabeculae, in which the native structural relationships between the full complement of proteins in the regulatory system are preserved. We attached bifunctional fluorescent probes to pairs of sites on specific α-helices of troponin, and the polarization of the fluorescence reports the orientation of each helix with respect to the actin filament or muscle cell axis. The probe attachment sites were chosen using the high resolution structures of isolated troponin components, and engineered by expressing mutants of troponin C (TnC, the component of troponin containing the regulatory Ca2+ site) with cysteines at the chosen sites (Fig. 1A; Takeda et al. 2003). One TnC mutant had cysteines at residues 55 and 62 (yellow spheres) on the C helix in the N-terminal lobe (red) of TnC, which contains the regulatory Ca2+ site (black sphere). Another TnC mutant had cysteines at positions 95 and 102 along the E helix in the IT arm, which is composed of the C-terminal half of TnC (green) containing two Ca2+/Mg2+ binding sites (grey), and parts of troponin I (TnI, blue) and troponin T (TnT, gold).

Figure 1. Orientation changes of the C and E helices of troponin C on binding Ca2+.

Figure 1

A, structure of core complex of cardiac troponin in the Ca2+-saturated form (ref 4; PDB 1J1D); containing troponin C (TnC; red, green) and parts of troponin I (TnI; blue, cyan) and troponin T (TnT; gold). Bifunctional rhodamine probes cross-linked either cysteines 55 and 62 (yellow spheres) along the C helix or 95 and 102 along the E helix of TnC. B and C, orientation (θf, circles) of the C and E helices of TnC, respectively, and isometric force (triangles) in the same sets of trabeculae in the presence of 5 mm MgATP. The dashed and continuous lines are fits of the Hill equation to θf and force, respectively. Error bars denote s.e.m. for n= 5 trabeculae.

The pair of cysteines in each of these TnC mutants was cross-linked with bifunctional rhodamine (BR) (Corrie et al. 1999; Ferguson et al. 2003; Sun et al. 2006), and each BR–TnC was separately exchanged for the native TnC of demembranated trabeculae from rat ventricle. Thus the two probes used here report changes in the orientation of the two major domains of the troponin core complex, the regulatory lobe of TnC and the IT arm, during Ca2+-dependent activation in the cellular environment. The relative orientation of these two domains differs substantially between published crystal structures of the core complex (Takeda et al. 2003; Vinogradova et al. 2005), and a change in this relative orientation may play a key role in the regulatory mechanism (Sun et al. 2006). We also investigated the role of myosin in the regulatory mechanism by inhibiting active force with blebbistatin (Straight et al. 2003; Dou et al. 2007; Farman et al. 2008), and by inducing rigor binding of myosin heads by MgATP depletion.

Methods

Animals

Wistar rats (200–250 g) were stunned and killed by cervical dislocation (Schedule 1 procedure in accordance with UK Animal (Scientific Procedures) Act, 1986). The hearts were removed and rinsed free of blood in Krebs solution containing (mm): NaCl, 118; NaHCO3, 24.8; Na2HPO4, 1.18; MgSO4, 1.18; KCl, 4.75; CaCl2, 2.54; glucose, 10; bubbled with 95% O2–5% CO2; pH 7.4 at 20°C. Suitable trabeculae (free running, unbranched, diameter <250 μm) were dissected from the right ventricle in Krebs solution containing 25 mm 2,3-butanedione-monoxime, permeabilized in relaxing solution (see below) containing 1% Triton X-100 for 30 min, and stored in relaxing solution containing 50% (v/v) glycerol at −20°C for experiments, normally within 2 days of dissection.

Preparation of BR-labelled troponin C

Double cysteine mutants E55C/D62C and E95C/R102C of human cardiac TnC in the Pet3a expression vector were obtained by site-directed mutagenesis and expressed in E. coli. C35 and C84 were replaced by serine. TnC was expressed, purified and labelled as previously described for the skeletal isoform (Ferguson et al. 2003). The cysteines were cross-linked with bifunctional rhodamine (BR) to form 1 : 1 BR : TnC conjugates (Corrie et al. 1998), and purified to > 95% homogeneity by reverse-phase HPLC. Stoichiometry and specificity of BR-labelling were confirmed by electrospray mass spectrometry. The measured mass of TnC with BR cross-linking residues 55 and 62 (TnC-BR55-62) was 18 858.5 ± 0.9 Da (calculated mass 18 858.6 Da), and that of TnC-BR95-102 was 18 817.9 ± 0.8 Da (calculated mass 18 817.3 Da).

Reconstitution of TnC into ventricular trabeculae

Demembranated trabeculae were mounted, via aluminium T-clips, at sarcomere length 2.1–2.2 μm between a force transducer (AE 801) and a fixed hook in a 60 μl glass trough containing relaxing solution. The experimental temperature was 20–22°C.

Experimental solutions contained 25 mm imidazole, 5 mm MgATP (except rigor solutions), 1 mm free Mg2+, 10 mm EGTA (except pre-activating solution), 0–10 mm total calcium, 1 mm dithiothreitol and 0.1% (v/v) protease inhibitor cocktail (P8340, Sigma). Ionic strength was adjusted to 200 mm with potassium propionate; pH was 7.1 at 20°C. The purity of EGTA (E4378, Sigma) was 98.7% according to the manufacturer's analysis. The concentration of free Ca2+ was calculated using the program WinMAXC V2.5 (http://www.stanford.edu/~cpatton/maxc.html). The calculated free [Ca2+] was in the range 1 nm to 63 μm in the presence of MgATP and 1 nm to 158 μm in its absence. In pre-activating solution, [EGTA] was 0.2 mm and no calcium was added. When required, 25 μm blebbistatin (B0560, Sigma) was added from a 10 mm stock solution in DMSO.

Native TnC was extracted from trabeculae by incubation in 0.5 mm trifluoperazine (Fluka 91665), 20 mm Mops, 5 mm EDTA and 130 mm potassium propionate, pH 7.0, 20°C for 30 s, followed by 30 s in relaxing solution. After 20–25 such cycles, the residual force at maximal Ca2+ activation at [Ca2+]= 63 μm was 30 ± 3% (n= 14) of its pre-extraction value, indicating that about two-thirds of the native TnC had been removed. Trifluoperazine as used in this TnC extraction protocol has no other effect on the structure or function of skeletal muscle fibres (Ferguson et al. 2003; Sun et al. 2006). Trabeculae were then incubated in relaxing solution containing 1.8 mg ml−1 TnC-BR55-62 or TnC-BR95-102 for 30 min at 20°C, and the extent of TnC reconstitution was estimated from force at maximal Ca2+ activation. No further increase in force was produced by longer incubation in TnC.

Measurement of TnC helix orientation by polarized fluorescence

Polarized fluorescence intensities were measured as previously described for skeletal muscle fibres (Sun et al. 2006). A central 0.7 mm segment of a trabecula was briefly illuminated from below with 532 nm light polarized either parallel or perpendicular to the trabecular axis. BR fluorescence at 610 nm was collected both in line with the illuminating beam and at 90 deg to both the illuminating beam and the trabecular axis. Each emitted beam was separated into parallel and perpendicular components, and three independent orientation order parameters were calculated from the measured intensities: <P2d, describing the amplitude of rapid (subnanosecond) probe motion and <P2 and <P4, describing the distribution of angles θ between BR fluorescence dipole and thin filament axis averaged over slower time scales (Dale et al. 1999). A mean θ was estimated for a Gaussian orientation distribution (standard deviation σg) and reported as θf, the mean axial angle of the distribution in the trabecular co-ordinate frame formed by folding the tail of the molecular Gaussian distribution into the region of positive θ (Julien et al. 2007).

Each trabecular activation was preceded by a 1 min incubation in pre-activating solution. Isometric force and fluorescence intensities were measured after steady-state force had been established in each activation. Maximum force was recorded before and after each series of activations at submaximal [Ca2+], and was 37.9 ± 1.6 mN mm−2 (cross-sectional area 18 724 ± 2242 μm2, n= 14) before TnC extraction. If the maximum force decreased by >15%, the trabecula was discarded. The dependence of force and θf on [Ca2+] was fitted to data from individual trabeculae using non-linear least-squares regression to the Hill equation:

graphic file with name tjp0587-0155-m1.jpg

where EC50 is the [Ca2+] corresponding to half-maximal change in Y, and nH is the Hill coefficient. All values are given as mean ± standard error of the mean except where noted, with n representing the number of trabeculae.

Results

Incorporation of labelled TnC into cardiac muscle cells

The in situ orientation of the C helix of TnC in the N-terminal regulatory lobe (Fig. 1A) was determined by replacing about two-thirds of the native TnC of demembranated ventricular trabeculae by TnC-BR55-62, in which residues 55 and 62 were cross-linked with bifunctional rhodamine (BR). Maximum Ca2+-activated isometric force after TnC exchange was 82 ± 3% (n= 5) of that before exchange (Table 1). Incorporation of unlabelled wild-type TnC by the same protocol produced the same small reduction of maximum force, consistent with a non-specific effect of the TnC exchange protocol. The dependence of force after TnC exchange on free [Ca2+] was fitted by the Hill equation (Fig. 1B, triangles). The [Ca2+] giving half-maximum force (EC50) was 5.40 ± 0.57 μm (n= 5), and the Hill coefficient (nH), describing the steepness of the Ca2+ dependence, was 3.10 ± 0.24 (Table 1). EC50 clearly increased following TnC exchange, but nH did not change significantly (P > 0.05, paired comparison).

Table 1.

Ca2+ dependence of isometric force (mean ±s.e.m.)

C helix; TnC-BR55-62 (n= 5) E helix; TnC-BR95-102 (n= 5) Wild-type TnC (n= 4)
Before TnC reconstitution
EC50m) 2.53 ± 0.21 1.82 ± 0.33 1.29 ± 0.25
nH 3.51 ± 0.48 3.59 ± 0.15 3.57 ± 0.45
After TnC reconstitution
Maximum force 0.82 ± 0.03 0.84 ± 0.02 0.82 ± 0.01
EC50m) 5.40 ± 0.57 3.17 ± 0.49 1.54 ± 0.30
nH 3.10 ± 0.24 2.92 ± 0.25 3.13 ± 0.43

EC50 and nH are fitted parameters of the Hill equation (see Methods). Maximum Ca2+-saturated force was measured after TnC exchange as a fraction of that in the same trabeculae before exchange.

The orientation of the E helix in the C-terminal lobe of TnC, part of the IT arm in the troponin ternary complex (Fig. 1A), was determined using a TnC mutant with bifunctional rhodamine cross-linking residues 95 and 102 (TnC-BR95-102). Active isometric force after replacement of native TnC by TnC-BR95-102 was 84 ± 2% (n= 5) of that before TnC exchange (Table 1). EC50 for force increased after the introduction of TnC-BR95-102, but there was no significant change in nH. Thus, as in case of the C helix probe, introduction of the BR probe on the E helix of TnC reduced the Ca2+ affinity of the regulatory site of TnC with no significant effect on the steepness of the force–Ca2+ relationship. The reduced Ca2+ affinity appears to be related to the presence of the BR probe on either the C or E helix, since there was no significant change in EC50 following exchange of wild-type TnC (Table 1).

In situ orientation of the C and E helices of troponin C

The orientation of the BR fluorescence dipole, and thus of the C or E helix of TnC to which it was attached, was determined from the polarization of fluorescence from trabeculae containing BR-TnC (Corrie et al. 1999; Ferguson et al. 2003; Sun et al. 2006). For a cylindrically symmetrical muscle cell, the results can be expressed in terms of a set of order parameters that describe the orientation distribution of the BR dipoles with respect to the trabecular axis (Dale et al. 1999), and these order parameters are reported in Supplemental Table 1 in the online Supplemental material. We used a Gaussian model of these dipole orientation distributions with peak angle θf and standard deviation σg (Julien et al. 2007) to describe the main features of the orientation changes. θf increased by about 5 deg on Ca2+ activation of the trabeculae, for both the C helix (Fig. 1B, circles) and the E helix (Fig. 1C, circles; Table 2). Although these orientation changes are small, they were highly reproducible. There was no significant change in probe dispersion σg on Ca2+ activation.

Table 2.

Ca2+ dependence of troponin C orientation parameters

C helix; TnC-BR55-62 E helix; TnC-BR95-102
5 mm MgATP (n= 5) 5 mm MgATP + 25 μm blebbistatin (n= 4) 0 mm MgATP, rigor (n= 5) 5 mm MgATP (n= 5) 5 mm MgATP + 25 μm blebbistatin (n= 4) 0 mm MgATP, rigor (n= 4)
θf (deg)
1 nm[Ca2+] 52.3 ± 0.2   52.2 ± 0.2 ns 54.8 ± 0.1 * 46.3 ± 0.2  45.5 ± 0.1  54.4 ± 0.4 
Maximal [Ca2+] 57.4 ± 0.2  57.0 ± 0.2 * 57.9 ± 0.1 * 50.0 ± 0.3  48.4 ± 0.2  56.9 ± 0.4 
First Hill fit
Amplitude (deg)  5.04 ± 0.12  4.81 ± 0.05 1.12 ± 0.27 4.29 ± 0.34 3.70 ± 0.26 0.95 ± 0.20
EC50m)  6.01 ± 0.54   7.29 ± 0.71 * 4.83 ± 0.44 4.60 ± 0.50 7.39 ± 1.00 4.37 ± 0.45
nH  3.01 ± 0.13    2.86 ± 0.27 ns 2.24 ± 0.33 3.06 ± 0.32 2.85 ± 0.13 2.21 ± 0.64
Second Hill fit
Amplitude (deg) 1.97 ± 0.20 1.59 ± 0.18
EC50m) 0.28 ± 0.08 0.25 ± 0.05
nH 1.05 ± 0.12 0.73 ± 0.04
σg (deg)
1 nm[Ca2+] 24.3 ± 0.4 24.9 ± 0.2 27.4 ± 1.3  22.9 ± 0.4  23.4 ± 0.5  30.2 ± 2.2 
Maximal [Ca2+] 24.8 ± 0.6 25.1 ± 0.3 26.0 ± 1.1  22.6 ± 0.6  22.5 ± 0.5  30.8 ± 2.8 

Mean ±s.e.m. Comparison: paired t test, two-tailed; nsP > 0.05;

*

P < 0.05.

The Ca2+ dependence of the θf changes was described using the Hill equation, which gave a good fit to the data for the C helix probe (Fig. 1B, dashed line), with EC50 6.01 ± 0.54 μm and nH 3.0 ± 0.1 (n= 5). These values were not significantly different from those for force in the same trabeculae (Fig. 1B, triangles, continuous line). θf for the E helix probe (Fig. 1C, circles) showed a small additional component in the subthreshold range for activation, as observed previously for monofunctional probes on Cys84 of TnC (Bell et al. 2006). This component, which may be associated with Ca2+ binding to the Ca2+/Mg2+ sites near the E helix (Fig. 1A), could be partly responsible for the offset between the Ca2+ dependence of θf for this probe and force (Fig. 1C). The major component of the E helix orientation change for [Ca2+] > 1 μm was fitted to the Hill equation (dashed line), with EC50= 4.60 ± 0.50 μm. nH was close to 3, similar to that for force in these trabeculae, and to the values reported above for the C helix (Table 2).

The EC50 values for the major component of the changes in orientation of the C and E helices are consistent with the Ca2+ affinity of the regulatory site of troponin (Holroyde et al. 1980; Pan & Solaro, 1987). The structural changes in both regions of troponin have a Ca2+ dependence similar to that of force. Thus, as [Ca2+] is varied, force is linearly related to the structural change in troponin, as expected for a simple two-state model in which troponin molecules are in either a Ca2+-free OFF or a Ca2+-bound ON state, with force proportional to the fraction ON. Ca2+ control of both the structural change and force is highly co-operative, however, as indicated by nH values close to 3.

Effect of force-generating myosin heads on troponin orientation

To determine the effect of force-generating myosin heads on these changes in troponin structure, we reduced active force to 1.6 ± 0.6% (n= 8) of the control value using 25 μm blebbistatin. This is a small molecule which binds specifically with high affinity to the actin-binding cleft of cardiac myosin, preventing strong binding to actin (Straight et al. 2003; Allingham et al. 2005), and inhibiting actomyosin ATPase activity (Kovacs et al. 2004; Farman et al. 2008) and active force generation by cardiac muscle (Dou et al. 2007; Farman et al. 2008). The Ca2+ dependence of the orientation of the C helix of TnC after inhibition of active force by blebbistatin (Fig. 2A, circles) was almost identical to that in control conditions (dashed line). EC50 increased slightly (P < 0.05, paired comparison), but there was no significant change in nH, which remained close to 3 (Table 2). These results provide strong evidence that the co-operativity of the Ca2+-dependent change in troponin structure is not due to force-generating myosin heads. Similar results were obtained for the E helix probe (Fig. 2B), although here the quantitative interpretation is complicated by the biphasic orientation change noted above. Unexpectedly, blebbistatin reduced θf for the E helix by about 1 deg over the whole range of [Ca2+]. The Hill equation fit to θf for [Ca2+] > 1 μm (continuous line) again had nH close to 3 (Table 2), as in control conditions (dashed line), and EC50 was larger than in control conditions (P < 0.05), as observed for the C helix probe.

Figure 2. Effect of force inhibition by 25 μm blebbistatin on the orientation of the C helix (A) and the E helix (B) of TnC in the presence of 5 mm MgATP.

Figure 2

Circles denote θf in the presence of blebbistatin, continuous lines denote Hill fits to these data, and dashed lines are from the Hill fits in Fig. 1, in the absence of blebbistatin.

Effect of myosin head binding in rigor on troponin orientation

The results described in the previous section show that the steep Ca2+ dependence of active force generation is not due to binding of force-generating myosin heads to the thin filaments. However, it is well established that myosin head binding can activate the thin filaments at very low [MgATP], when myosin makes a rigor bond with actin (Bremel & Weber, 1972). Myosin binding in rigor conditions also increases the Ca2+ affinity of TnC (Rosenfeld & Taylor, 1985; Robinson et al. 2004). To clarify the mechanisms operating in the two sets of conditions, we measured the structural changes in TnC using the C and E helix TnC probes in ventricular trabeculae in rigor conditions.

Binding of myosin heads to actin in rigor conditions produced changes in the orientation of both helices even at 1 nm[Ca2+] (Table 2). θf for the C helix increased by 2.5 deg and θf for the E helix by ca 8 deg. The change in the orientation of the E helix was larger than that produced by Ca2+ binding during physiological activation at 5 mm MgATP. Binding of rigor heads also increased the dispersion of the probe orientations (σg); for example, σg for the E helix probe increased from 22.9 ± 0.4 deg at 5 mm MgATP to 30.2 ± 2.2 deg in rigor at 1 nm[Ca2+]. This broadening of the orientation distributions in rigor contrasts with the absence of any significant change in σg when trabeculae were activated at 5 mm MgATP (Table 2).

Addition of Ca2+ in rigor produced further increases in θf (Fig. 3A and B, circles; Table 2), but these were spread over a much wider range of [Ca2+] than during physiological activation at 5 mm MgATP (dashed lines). For quantitative analysis of the Ca2+ dependence in rigor, we took into account that only about two-thirds of the troponin molecules in trabeculae at sarcomere length 2.15 μm are located in the overlap region of the thin filament where myosins are available for binding (Fig. 3, inset). The θf data (Fig. 3, circles) were therefore fitted by the sum of two Hill equations (continuous lines), with the relative amplitude of the two components as a free parameter. The best fit was obtained when two-thirds of the total angle change was accounted for by a component with EC50 0.25–0.28 μm and nH 0.7–1.1 for both the C and E helix probes (Table 2) that we associate with the overlap region (black arrow). These values of EC50 and nH are similar to those measured for conformational changes of troponin in the rigor complex in solution (Robinson et al. 2004). The remaining one-third was accounted for by a component with EC50 4.4–4.8 μm for both the C and E helices, close to that for physiological activation at 5 mm MgATP, associated with the non-overlap region (grey arrow). nH for this component could not be determined precisely, but was 2.2 ± 0.3 and 2.2 ± 0.6 for the C and E helices, respectively, consistent with a degree of co-operativity that is similar to or somewhat lower than that measured during physiological activation. These results suggest that, even in rigor conditions, the non-overlap region of the thin filament exhibits a co-operative structural change on binding Ca2+ that is independent of local myosin binding.

Figure 3. The orientation of the C helix (A) and the E helix (B) of TnC in the absence of MgATP.

Figure 3

Circles denote θf, continuous lines denote double Hill equation fits described in the text, and dashed lines are from the Hill fits in Fig. 1 for 5 mm MgATP. The inset shows the degree of overlap between the myosin and thin filaments at the sarcomere length used in these experiments.

Discussion

Co-operative Ca2+ regulation of cardiac contractility is intrinsic to the thin filament

The results presented above can be explained by a simple two-state model for Ca2+ regulation of contraction in heart muscle. The Ca2+-driven transition between the two states is co-operative, in the sense that the Ca2+ dependence of changes in troponin structure and force both have a Hill coefficient (nH) close to 3. However, this co-operativity is not due to force-generating myosin heads, because it is not affected by specific inhibition of active force by blebbistatin. We conclude that the mechanism of co-operativity must be intrinsic to the thin filaments. Such a mechanism has been inferred previously from solution studies, and is likely to involve tropomyosin-mediated coupling between troponin monomers along the thin filament and/or between its two strands (Tobacman & Sawyer, 1990; Tobacman, 1996; Galinska-Rakoczy et al. 2008). The present conclusion is at variance with the alternative hypothesis that myosin binding plays a dominant role in switching on the thin filaments during activation of heart muscle, and three-state model of regulation associated with this concept (McKillop & Geeves, 1993; Gordon et al. 2000; Kobayashi & Solaro, 2005). The next three sections reconsider the evidence for the myosin activation hypothesis in the light of the present results.

Rigor and active force-generating myosin heads have distinct effects on troponin structure

Activation of thin filaments by rigor binding of myosin heads, accompanied by an order of magnitude increase in the affinity of troponin for Ca2+, is a well-established phenomenon (Bremel & Weber, 1972; Rosenfeld & Taylor, 1985; Robinson et al. 2004), and the rigor state has been widely used as a convenient model for the force-generating myosin heads during active contraction at physiological [MgATP] in both molecular- and cell-level studies. The present results, however, show that rigor and force-generating myosin heads have distinct effects on Ca2+-dependent changes in troponin structure. In rigor, the change in troponin structure is characterized by a Ca2+ affinity an order of magnitude greater than in physiological conditions, but there is no co-operativity (nH close to 1), in contrast with physiological conditions (nH close to 3). Ca2+ titrations in rigor indicated the presence of two populations of troponin molecules, corresponding to those in the overlap region of the sarcomere where rigor heads have an effect, and the non-overlap region where they do not. The larger Gaussian width (σg) of the orientation distributions in rigor also suggests the presence of two populations of troponin molecules. At physiological [MgATP], in contrast, only one population of troponin molecules is present, implying that troponins in the overlap and non-overlap regions of the sarcomere have the same Ca2+ dependence and providing further evidence for the absence of an effect of active force-generating myosin heads on troponin structure. In summary, the present results show that the effect of myosin binding to actin in rigor conditions is not a reliable model for its effect on troponin structure and thin filament activation under physiological conditions.

Previous studies of troponin structure and Ca2+ binding in muscle cells

The present work differs from previous studies that used extrinsic probes to investigate changes in troponin structure in heart muscle at physiological [MgATP] in two key respects. First, we used bifunctional probes to measure the orientation of specific troponin helices; previous studies used monofunctional probes in which the orientation and motion of the probe with respect to the protein was unknown, and different results were obtained with different probe sites (e.g. Putkey et al. 1997; Martyn et al. 2001). Second, none of the previous studies used blebbistatin to inhibit active force generation and thereby determine the role of force-generating myosin heads on thin filament activation. Blebbistatin is a more potent and specific inhibitor than the millimolar vanadate used in previous studies of structural changes in TnC reported by fluorescent probes (Martyn et al. 2001; Bell et al. 2006) and of direct Ca2+ binding (Hofmann & Fuchs, 1987; Wang & Fuchs, 1994). TnC can be extracted from skeletal muscle fibres in solutions containing millimolar vanadate (Allhouse et al. 1999; Agianian et al. 2004), and both TnC and TnI are extracted from cardiac muscle in these conditions (Strauss et al. 1992). Thus the effects of vanadate reported in previous studies of troponin structure and Ca2+ binding may not have been solely due to its inhibition of myosin.

Shortening dependence of Ca2+ activation

Shortening of heart muscle cells during activation produces a transient increase in intracellular free [Ca2+] (Allen & Kurihara, 1982; Gordon & Ridgway, 1987; Allen & Kentish, 1988), indicating a decrease in the Ca2+ affinity of troponin. Since fewer myosin heads are bound to thin filaments during shortening, these transient [Ca2+] increases suggest that myosin head binding can affect the Ca2+ affinity of troponin under physiological conditions, in apparent contradiction with the present results. However, the affinity change implied by these [Ca2+] transients is small. For example, with nH= 3 and free [Ca2+]= 6 μm an increase in EC50 from 6 to 7 μm, similar to that observed for the C helix probe when force was inhibited by blebbistatin (Table 1), would release about 8 μm total Ca2+ from the ca 70 μm troponin in a heart muscle cell. This could account for the observed changes in free [Ca2+] given reasonable estimates of intracellular Ca2+ buffering (Berlin et al. 1994). The small increase in EC50 associated with force inhibition suggests that the troponin ON state is slightly favoured by binding of force-generating myosin heads, as expected from a regulatory mechanism in which both processes are coupled to tropomyosin movement. This small effect of force-generating myosin heads on Ca2+ affinity (an order of magnitude smaller than that of rigor myosin heads) might be accompanied by a similarly small effect of force inhibition by blebbistatin on the Hill coefficient nH (Table 1), although no such change was detectable at the 5% significance level in the present experiments. The finding that almost normal co-operativity of Ca2+ regulation was maintained in the presence of blebbistatin argues strongly against a dominant role for myosin-dependent affinity changes in the co-operative response to Ca2+ binding.

Changes in troponin structure during Ca2+ activation

The change in troponin structure during activation of ventricular trabeculae reported by probes on the C and E helices of TnC corresponds to a change in the angle between each helix and the actin filament axis of only about 5 deg. In isolated TnC in solution, the angle between the C and D helices of TnC changes by 12 deg on binding Ca2+, and by 34 deg on binding both Ca2+ and the switch peptide (residues 147–163) of TnI (Sia et al. 1997; Li et al. 1999). These C/D angle changes are associated with opening of the N-lobe of TnC, exposing a hydrophobic binding site for the TnI switch peptide, and are thought to represent an essential step in the signalling pathway that leads to muscle activation. The present results do not exclude the possibility that the N-lobe opens in this way during physiological activation of heart muscle, but if so the motion of the C helix must be predominantly azimuthal, i.e. around the filament axis. Further experiments with probes at other sites on TnC will be required to characterize this motion and measure the extent of N-lobe opening in situ. However, the comparison of the ca 5 deg C helix tilt observed here with the ca 27 deg tilt of the same helix in skeletal muscle (Sun et al. 2006) already shows that the underlying conformational changes in the N-lobe of TnC on activation are different in skeletal and cardiac muscle. In skeletal muscle, the whole N-lobe seems to tilt substantially with respect to the C-lobe, IT arm and thin filament during activation (Sun et al. 2006). The present results suggest that this motion does not occur in cardiac muscle, but the structural basis and physiological significance of this difference remain to be elucidated.

Acknowledgments

We are grateful to Dr J. E. T. Corrie for the bifunctional rhodamine, Professor B. D. Sykes for the DNA for cardiac TnC, Dr R. Thorogate for help with mass spectrometry, Professor J. C. Kentish for help and advice on the trabecular preparation and solutions, and comments on the manuscript. This work was supported by the British Heart Foundation (FS/04/083).

Supplemental material

Online supplemental material for this paper can be accessed at:

tjp0587-0165-SD1.pdf (244.2KB, pdf)

http://jp.physoc.org/cgi/content/full/jphysiol.2008.164707/DC1

References

  1. Agianian B, Krzic U, Qiu F, Linke WA, Leonard K, Bullard B. A troponin switch that regulates muscle contraction by stretch instead of calcium. EMBO J. 2004;23:772–779. doi: 10.1038/sj.emboj.7600097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen DG, Kentish JC. Calcium concentration in the myoplasm of skinned ferret ventricular muscle following changes in muscle length. J Physiol. 1988;407:489–503. doi: 10.1113/jphysiol.1988.sp017427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allen DG, Kurihara S. The effects of muscle length on intracellular calcium transients in mammalian cardiac muscle. J Physiol. 1982;327:79–94. doi: 10.1113/jphysiol.1982.sp014221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Allhouse LD, Potter JD, Ashley CC. A novel method of extraction of TnC from skeletal muscle myofibrils. Pflugers Arch. 1999;437:695–701. doi: 10.1007/s004240050834. [DOI] [PubMed] [Google Scholar]
  5. Allingham JS, Smith R, Rayment I. The structural basis of blebbistatin inhibition and specificity for myosin II. Nat Struct Mol Biol. 2005;12:378–379. doi: 10.1038/nsmb908. [DOI] [PubMed] [Google Scholar]
  6. Bell MG, Lankford EB, Gonye GE, Ellis-Davies GCR, Martyn DA, Regnier M, Barsotti RJ. Kinetics of cardiac thin-filament activation probed by fluorescence polarization of rhodamine-labelled troponin C in skinned guinea pig trabeculae. Biophys J. 2006;90:531–543. doi: 10.1529/biophysj.105.072769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Berlin JR, Bassani JWM, Bers DM. Intrinsic cytosolic calcium buffering properties of single rat cardiac myocytes. Biophys J. 1994;67:1775–1787. doi: 10.1016/S0006-3495(94)80652-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bremel RD, Weber A. Cooperation within the actin filament in vertebrate skeletal muscle. Nat New Biol. 1972;238:97–101. doi: 10.1038/newbio238097a0. [DOI] [PubMed] [Google Scholar]
  9. Corrie JET, Brandmeier BD, Ferguson RE, Trentham DR, Kendrick-Jones J, Hopkins SC, van der Heide UA, Goldman YE, Sabido-David C, Dale RE, Criddle S, Irving M. Dynamic measurement of myosin light-chain domain tilt and twist in muscle contraction. Nature. 1999;400:425–430. doi: 10.1038/22704. [DOI] [PubMed] [Google Scholar]
  10. Corrie JET, Craik JS, Munasinghe VRN. A homobifunctional rhodamine for labeling proteins with defined orientations of a fluorophore. Bioconjug Chem. 1998;9:160–167. doi: 10.1021/bc970174e. [DOI] [PubMed] [Google Scholar]
  11. Dale RE, Hopkins SC, van der Heide UA, Irving M, Goldman YE. Model-independent analysis of the orientation of fluorescent probes with restricted mobility in muscle fibers. Biophys J. 1999;76:1606–1618. doi: 10.1016/S0006-3495(99)77320-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dou Y, Arlock P, Arner A. Blebbistatin specifically inhibits actin–myosin interaction in mouse cardiac muscle. Am J Physiol Cell Physiol. 2007;293:C1148–C1153. doi: 10.1152/ajpcell.00551.2006. [DOI] [PubMed] [Google Scholar]
  13. Farman GP, Tachampa K, Mateja R, Cazorla O, Lacampagne A, de Tombe PP. Blebbistatin: use as inhibitor of muscle contraction. Pflugers Arch. 2008;455:995–1005. doi: 10.1007/s00424-007-0375-3. [DOI] [PubMed] [Google Scholar]
  14. Ferguson RE, Sun Y-B, Mercier P, Brack AS, Sykes BD, Corrie JET, Trentham DR, Irving M. In situ orientations of protein domains: troponin C in skeletal muscle fibers. Mol Cell. 2003;11:865–874. doi: 10.1016/s1097-2765(03)00096-0. [DOI] [PubMed] [Google Scholar]
  15. Galinska-Rakoczy A, Engel P, Xu C, Jung H, Craig R, Tobacman LS, Lehman W. Structural basis for the regulation of muscle contraction by troponin and tropomyosin. J Mol Biol. 2008;379:929–935. doi: 10.1016/j.jmb.2008.04.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol Rev. 2000;80:853–924. doi: 10.1152/physrev.2000.80.2.853. [DOI] [PubMed] [Google Scholar]
  17. Gordon AM, Ridgway EB. Extra calcium on shortening in barnacle muscle. Is the decrease in calcium binding related to decreased cross-bridge attachment, force, or length? J Physiol. 1987;90:321–340. doi: 10.1085/jgp.90.3.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hofmann PA, Fuchs F. Evidence for a force-dependent component of calcium binding to cardiac troponin C. Am J Physiol Cell Physiol. 1987;253:C541–C546. doi: 10.1152/ajpcell.1987.253.4.C541. [DOI] [PubMed] [Google Scholar]
  19. Holroyde MJ, Robertson SP, Johnson JD, Solaro RJ, Potter JD. The calcium and magnesium binding sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem. 1980;255:11688–11693. [PubMed] [Google Scholar]
  20. Julien O, Sun Y-B, Knowles AC, Brandmeier BD, Dale RE, Trentham DR, Corrie JET, Sykes BD, Irving M. Toward protein structure in situ: comparison of two bifunctional rhodamine adducts of troponin C. Biophys J. 2007;93:1008–1020. doi: 10.1529/biophysj.107.103879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kobayashi T, Solaro RJ. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol. 2005;67:39–67. doi: 10.1146/annurev.physiol.67.040403.114025. [DOI] [PubMed] [Google Scholar]
  22. Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, Sellers JR. Mechanism of blebbistatin inhibition of myosin II. J Biol Chem. 2004;279:35557–35563. doi: 10.1074/jbc.M405319200. [DOI] [PubMed] [Google Scholar]
  23. Li MX, Spyracopoulos L, Sykes BD. Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C. Biochemistry. 1999;38:8289–8298. doi: 10.1021/bi9901679. [DOI] [PubMed] [Google Scholar]
  24. McKillop DF, Geeves MA. Regulation of the interaction between actin and myosin subfragment 1: evidence for three states of the thin filament. Biophys J. 1993;65:693–701. doi: 10.1016/S0006-3495(93)81110-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Martyn DA, Regnier M, Xu D, Gordon AM. Ca2+- and cross-bridge-dependent changes in N- and C-terminal structure of troponin C in rat cardiac muscle. Biophys J. 2001;80:360–370. doi: 10.1016/S0006-3495(01)76020-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pan BS, Solaro RJ. Calcium-binding properties of troponin C in detergent-skinned heart muscle fibers. J Biol Chem. 1987;262:7839–7849. [PubMed] [Google Scholar]
  27. Putkey JA, Liu W, Lin X, Ahmed S, Zhang M, Potter JD, Kerrick WGL. Fluorescent probes attached to Cys 35 or Cys 84 in cardiac troponin C are differentially sensitive to Ca2+-dependent events in vitro and in situ. Biochemistry. 1997;36:970–978. doi: 10.1021/bi9617466. [DOI] [PubMed] [Google Scholar]
  28. Robinson JM, Dong W-J, Xing J, Cheung HC. Switching of troponin I: Ca2+ and myosin-induced activation of heart muscle. J Mol Biol. 2004;340:295–305. doi: 10.1016/j.jmb.2004.04.046. [DOI] [PubMed] [Google Scholar]
  29. Rosenfeld SS, Taylor EW. Kinetic studies of calcium binding to regulatory complexes from skeletal muscle. J Biol Chem. 1985;260:252–261. [PubMed] [Google Scholar]
  30. Sia SK, Li MX, Spyracopoulos L, Gagne SM, Liu W, Putkey JA, Sykes BD. Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain. J Biol Chem. 1997;272:18216–18221. doi: 10.1074/jbc.272.29.18216. [DOI] [PubMed] [Google Scholar]
  31. Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, Mitchison TJ. Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science. 2003;299:1743–1747. doi: 10.1126/science.1081412. [DOI] [PubMed] [Google Scholar]
  32. Strauss JD, Zeugner C, Van Eyk JE, Bletz C, Troschka M, Ruegg JC. Troponin replacement in permeabilized cardiac muscle. Reversible extraction of troponin I by incubation with vanadate. FEBS Lett. 1992;310:229–234. doi: 10.1016/0014-5793(92)81338-m. [DOI] [PubMed] [Google Scholar]
  33. Sun Y-B, Brandmeier B, Irving M. Structural changes in troponin in response to Ca2+ and myosin binding to thin filaments during activation of skeletal muscle. Proc Natl Acad Sci U S A. 2006;103:17771–17776. doi: 10.1073/pnas.0605430103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Takeda S, Yamashita A, Maeda K, Maeda Y. Structure of the core domain of human cardiac troponin in the Ca2+-saturated form. Nature. 2003;424:35–41. doi: 10.1038/nature01780. [DOI] [PubMed] [Google Scholar]
  35. Tobacman LS. Thin filament-mediated regulation of cardiac contraction. Annu Rev Physiol. 1996;58:447–481. doi: 10.1146/annurev.ph.58.030196.002311. [DOI] [PubMed] [Google Scholar]
  36. Tobacman LS, Sawyer D. Calcium binds cooperatively to the regulatory sites of the cardiac thin filament. J Biol Chem. 1990;265:931–939. [PubMed] [Google Scholar]
  37. Vinogradova MV, Stone DB, Malanina GG, Karatzaferi C, Cooke R, Mendelson RA, Fletterick RJ. Ca2+-regulated structural changes in troponin. Proc Natl Acad Sci U S A. 2005;102:5038–5043. doi: 10.1073/pnas.0408882102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wang YP, Fuchs F. Length, force, and Ca2+-troponin C affinity in cardiac and slow skeletal muscle. Am J Physiol Cell Physiol. 1994;266:C1077–C1082. doi: 10.1152/ajpcell.1994.266.4.C1077. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

tjp0587-0165-SD1.pdf (244.2KB, pdf)

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES